Unfortunately, most are given little guidance, risking issues like malnutrition, muscle loss, and fatigue as they lose weight
Missing two consecutive doses is more serious
Employer Benefits: Data on employer-provided coverage for GLP-1 agonists came from the KFF 2025 Employer Health Benefits Survey
Healthcare providers are incorporating these therapies into integrated care pathways for patients with multiple metabolic risk factors
Frequent asked questions What are GLP-1 receptor agonists, and how do they work
Growing up in Montreal, Canada, Drucker did his undergraduate studies at the University of Ottawa and then completed his internal medicine and endocrinology residencies at the University of Toronto, followed by postgraduate endocrinology training at Johns Hopkins Hospital